Skip to content

Nebulized Hypertonic Saline (3%) Versus Nebulized Adrenaline for Treatment of Bronchiolitis

Nebulized Hypertonic Saline (3%) Versus Nebulized Adrenaline for Treatment of Bronchiolitis: A Randomized Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03614273
Enrollment
60
Registered
2018-08-03
Start date
2015-03-01
Completion date
2016-02-29
Last updated
2018-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis

Keywords

nebulization, adrenaline, hypertonic saline, bronchiolitis

Brief summary

The primary objective of this study was to compare the effectiveness of nebulized hypertonic saline (3%) and nebulized adrenaline in bronchiolitis. The secondary objective was to assess whether non-responders to initial therapy benefit from continuation of the same therapy. This trial was conducted at a tertiary care teaching hospital over a period of one year in children with bronchiolitis presenting to the out-patient department and emergency. After obtaining a signed informed consent from the parents, all eligible children were assessed for baseline characteristics. A complete hemogram, chest X-ray were done in all and arterial blood gas analysis where ever required. Computer generated random numbers were used for enrolment in consecutive manner and patients were randomly assigned into two groups. The first group received one dose (4ml) of nebulized hypertonic saline (3%).The second group received one dose (0.1 mg/kg) of nebulized adrenaline diluted in normal saline to make it a 4ml solution. Supportive care (nasal clearing, antipyretics, oxygenation, intravenous fluids) was done in both groups as necessary. All children were reassessed 20 minutes after one dose of nebulization using the clinical score and a child was labelled as a responder if he showed an improvement in the clinical severity score by atleast 3 points after 20 minutes of nebulization. Both responders and non-responders were given a repeat dose of nebulization according to the group to which the child had been randomized, if: a) Severe audible wheeze with severe respiratory distress (severity score ≥9) b) Inability to maintain saturation \>92% even on an O2 flow of 4 L/min. Non responders were given a maximum of three continuous doses of nebulization. Child was considered fit for discharge if he/she was feeding well orally, there was no need for intravenous fluids, clinical severity score ≤3 and maintaining oxygen saturation \>92% on room air for a period of more than 12 hours.

Interventions

DRUGHypertonic saline

The nebulizations were administered via an oxygen run jet nebulizer, with a flow of 6-7 litres/min.

DRUGAdrenaline

The nebulizations were administered via an oxygen run jet nebulizer, with a flow of 6-7 litres/min.

Sponsors

Maulana Azad Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
1 Months to 2 Years
Healthy volunteers
No

Inclusion criteria

• Children aged 1 month to 2 years with moderate to severe bronchiolitis as per Wang score

Exclusion criteria

* Comorbidities such as congenital heart disease, bronchopulmonary dysplasia, cystic fibrosis, neurological diseases * Known or suspected immunodeficiency * Congenital malformations * History of use of steroids within one week prior to presentation * Severe disease requiring admission to intensive care unit/mechanical ventilation

Design outcomes

Primary

MeasureTime frameDescription
Duration of hospital stayDuring hospitalization, approximately 2 daysDuration from the time of enrolment to the point at which the discharge criteria (feeding well orally, no need for intravenous fluids, clinical severity score ≤ 3 and maintaining oxygen saturation \>92% on room air for a period of more than 12 hours) are met.

Secondary

MeasureTime frameDescription
Initial change in the Wang bronchiolitis clinical severity score20 minutes after the first nebulizationA decrease in the Wang bronchiolitis clinical severity score by at least 3 points after 20 minutes of nebulization was considered as an improvement in the clinical condition. The Wang score ranges from 0 - 12 \[0-4: mild, 5-8: moderate, 9-12: severe\].
Number of hours of intravenous fluid requirementDuring hospitalization, approximately 2 daysIntravenous fluids were given to children unable to accept orally.
Number of hours of oxygen requirementTill the time the child maintained a saturation of more than 94% for at least 4 hoursOxygen was administered when the saturation was less than 92%
Number of doses of nebulization neededDuring hospitalization, approximately 2 daysIndications for repeat dose were if: 1. The child had severe audible wheeze with severe respiratory distress (severity score ≥9) 2. The child was not able to maintain saturation \>92% even on an oxygen flow of 4 L/min
Response after each nebulizationAssessed 20 minutes after each nebulizationAn improvement in the clinical severity score by at least 3 points after each nebulization.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026